Sign In
Buy HBIO
$6.50
+0.0400 (+0.619%)
At Close: Jun 03, 2026
Harvard Bioscience (NASDAQ:HBIO) Stock Crosses Above 200-Day Moving Average – Here’s What Happened
03:32am, Wednesday, 03'rd Dec 2025
Harvard Bioscience, Inc. (NASDAQ: HBIO - Get Free Report) shares crossed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $0.49 and
Jeffrey Epstein files: Larry Summers steps back from public commitments over email fallout
08:28pm, Monday, 17'th Nov 2025
Former Treasury Secretary Larry Summers said he was stepping back from all public commitments amid fallout from the release of emails between him and sex offender Jeffrey Epstein. "I am deeply ashamed
Harvard Bioscience, Inc. (HBIO) Q3 2025 Earnings Call Transcript
02:16am, Friday, 07'th Nov 2025
Harvard Bioscience, Inc. ( HBIO ) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants John Duke - President, CEO & Director Mark Frost - Interim CFO, Treasurer, Principal Financial
Harvard Bioscience Announces Third Quarter 2025 Financial Results
07:00am, Thursday, 06'th Nov 2025
Reports Q3 2025 Revenues of $20.6M, Gross Margin of 58.4%, and Positive Cash Provided by Operations Company Expects to Refinance or Repay the Debt in the Fourth Quarter Fourth Quarter 2025 Guidance Re
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
08:00am, Thursday, 30'th Oct 2025
HOLLISTON, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2025, before the market opens on Nov
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
07:00am, Tuesday, 16'th Sep 2025
HOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), a leading provider of innovative laboratory equipment, is
Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors
07:00am, Tuesday, 09'th Sep 2025
HOLLISTON, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”) today announced the appointment of Stephen DeNelsky to its
Harvard Bioscience, Inc. (HBIO) Q2 2025 Earnings Call Transcript
09:54am, Monday, 11'th Aug 2025
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q2 2025 Earnings Conference Call August 11, 2025 8:00 AM ET Company Participants John Duke - President, CEO & Director Mark T. Frost - Interim CFO, Treasurer, P
Harvard Bioscience Announces Second Quarter 2025 Financial Results
07:00am, Monday, 11'th Aug 2025
Reports Q2 2025 Revenues of $20.5M, Gross Margin of 56.4%, and Positive Cash Provided by Operations Third Quarter 2025 Guidance Reflects Improved Operations and Strong Financial Discipline New Credit
Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET
04:30pm, Monday, 04'th Aug 2025
HOLLISTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2025, before the market opens on August 1
Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board
07:00am, Thursday, 17'th Jul 2025
HOLLISTON, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”) today announced a CEO succession plan under which John Duke
Harvard Bioscience Appoints John Duke to Board of Directors
04:57pm, Monday, 02'nd Jun 2025
HOLLISTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of John Duke to its board of directors, effective June
Harvard Bioscience, Inc. (HBIO) Q1 2025 Earnings Call Transcript
12:41pm, Monday, 12'th May 2025
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q1 2025 Earnings Conference Call May 12, 2025 8:00 AM ET Company Participants Kathryn Flynn - Corporate Controller Jim Green - Chairman, President & CEO Mark Fr
Harvard Bioscience Announces First Quarter 2025 Financial Results
07:00am, Monday, 12'th May 2025
HOLLISTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the first quarter ended March 31, 2025.
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET
04:45pm, Monday, 05'th May 2025
HOLLISTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2025, before the market opens on May 12,
